MAGNIFY phase IIIb interim analysis of induction R-2 followed by maintenance in relapsed/refractory indolent NHL.

Andorsky, DJ; Coleman, M; Yacoub, A; Melear, JM; Fanning, SR; Kolibaba, K; Lansigan, F; Reynolds, C; Foon, KA; Li, JH; Llorente, M; Rummel, MJ; Sharman, JP

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (15):